National Surveillance of the Use of New Antibiotics in Pediatrics and Multi- Resistant Bacteria Involved in Pediatric Infections
National Surveillance of the Use of New Antibiotics in Pediatrics and Multi- Resistant Bacteria Involved in Pediatric Infections
This study is observational, multicenter and prospective study for surveillance of the use of new antibiotics in pediatrics for treated pediatrics infections due to multi-resistant bacteria
The main of this study is to evaluate the relevance of prescribing "new antibiotics" according to the antibiogram of the isolated bacteria or in the absence of bacteriological documentation
As this is a surveillance study, the clinical and biological characteristics of the children included will be described.
Inclusion Criteria:
Children under 18 years of age
Hospitalized in France in a hospital center working with the ACTIV/GPIP network
Treated with one or more of the following antibiotics:
In association with a documented infection performed by:
Blood culture
Normally sterile site
Urine sampling if the bacteria was considered responsible for the infection (associated with a leukocyturia ≥10,0000)
Respiratory specimens if the bacteria was considered responsible for the infection
Sampling on material such as:Intubation probe, Orthopedic, Urological, Central Nervous System (CNS),....
Exclusion Criteria: